Short Communication on TGM2, with data on DNA/RNA, on the protein encoded and where the gene is implicated.
Function
Multifunctional enzyme with transglutaminase crosslinking activity (catalyze covalant bonds between the ε-amino group of a lysine and the γ-carboxyl group of a glutamine residue) stabilizing the extracellular matrix (ECM) and cell-ECM interaction; require Ca2+ for catalytic activity; inhibited by GTP; under stress (loss of Ca2+) may play a role in apoptosis; involved in wound healing and inflammation; aberrent overexpression of TG2 is linked to chemotherapeutic drug resistance.
Mutations

Germinal
No germinal mutations have been identified; low frequency of SNPs.
Somatic
No somatic mutations have been identified in cancer; can be transcriptionally silenced by CpG methylation in cancer (breast and brain); overexpression in many cancers; 3 missense mutations identified in early-onset type 2 diabetes patients (c.989T>G, c.992T>A, c.998A>G).
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Implicated in
Breast cancer
Oncogenesis Overexpression renders culture mammary epithelial cells resistant to doxorubicin, associated with invasive phenotype and epithelial-to-mesenchymal transition; epigenetic silencing has been documented in many breast cancer cell lines and patient samples. In 30 patients, TG2 overexpression was found more often in lymph node metastases than primary tumors.
Ovarian cancer
Prognosis
Overexpression of TG2 is associated with negative survival in 93 patients (p=0.007). Oncogenesis Overexpression renders ovarian cancer cells resistant to cisplatin and is associated with higher tumor stage.
Pancreatic cancer
Prognosis
Overall survival of stage II pancreatic ductal adenocarcinoma (PDAC) patients with TG2-mediated loss of PTEN was poor (20.7 months) compared to 68.6 months for TG2 negative and PTEN positive patients. Oncogenesis Overexpression; resistance to gemcitabine; in 51 PDAC tumor samples overexpression of TG2 was associated with loss of PTEN expression.
Non-small cell lung cancer (NSCLC)
Prognosis
In 429 Korean patients, TG2 expression was associated with shorter disease free survival and correlated with recurrence. Oncogenesis Overexpression ; cisplatin resistance.
Celiac disease
Autoantibodies against TG2; autoantibodies are deposited in the small-bowl mucosa; TG2 crosslinks gliadin peptides (gluten) derived.
